Segmented Negative Strand Viruses. Arenaviruses, Bunyaviruses, and Orthomyxoviruses

410 Pages·1984·25.873 MB·English

by  Richard W. Compans (Eds.)

Academic Press Rapid Manuscript Reproduction
Proceedings of a Symposium on the
Molecular Biology of Negative Strand Viruses
Sponsored by the University of Alabama in Birmingham
Held in Hilton Head, South Carolina
September 11-18, 1983
SEGMENTED
NEGATIVE STRAND
VIRUSES
Arenaviruses, Bunyaviruses,
and Orthomyxoviruses
Edited by
Richard W. Compans
David H. L Bishop
Department of Microbiology
University of Alabama in Birmingham
Birmingham, Alabama
1984
ACADEMIC PRESS, INC.
(Harcourt Brace Jovanovich, Publishers)
Orlando San Diego San Francisco New York London
Toronto Montreal Sydney Tokyo Säo Paulo
COPYRIGHT © 1984, BY ACADEMIC PRESS, INC.
ALL RIGHTS RESERVED.
NO PART OF THIS PUBLICATION MAY BE REPRODUCED OR
TRANSMITTED IN ANY FORM OR BY ANY MEANS, ELECTRONIC
OR MECHANICAL, INCLUDING PHOTOCOPY, RECORDING, OR ANY
INFORMATION STORAGE AND RETRIEVAL SYSTEM, WITHOUT
PERMISSION IN WRITING FROM THE PUBLISHER.
ACADEMIC PRESS, INC.
Orlando, Florida 32887
United Kingdom Edition published by
ACADEMIC PRESS, INC. (LONDON) LTD.
24/28 Oval Road, London NW1 7DX
Library of Congress Cataloging in Publication Data
Main entry under title:
Segmented negative strand viruses·
Proceedings of the 5th International Symposium on
Negative Strand Viruses, held at Hilton Head, S.C.,
Sept. 11-17, 1983.
Includes index.
1. Arenaviruses--Concjresses. 2. Bunyaviruses—Con­
gresses. 3. Orthomyxoviruses—Congresses. I. Compans,
Richard W. II. Bishop, David H. L. III. International
Symposium on Negative Strand Viruses (5th : 1983 :
Hilton Head, S.C.) [DNLM: 1. Arenaviridae--Congresses.
2. Bunyaviridae--Congresses. 3. Orthomyxoviridae--Con-
gresses. QW 168 S454 1983]
QR395.S44 1984 576 '.64 84-6276
ISBN 0-12-183501-4 (alk. paper)
PRINTED IN THE UNITED STATES OF AMERICA
84 85 86 87 9 8 7 6 5 4 3 2 1
Contributors
Numbers in parentheses indicate the pages on which the authors' contributions begin.
Gordon Abraham (37), School of Science, Griffith University, Nathan, Queensland
4111, Australia
Rafi Ahmed (333), Department of Immunology, Scripps Clinic and Research
Foundation, La Jolla, California 92037
Katsutoshi Aihara1 (387), Department of Bacteriology, Nagasaki University School
of Medicine, Nagasaki 852, Japan
G. M. Air2 (225), John Curtin School of Medical Research, Canberra City, ACT
2601, Australia
Hiroomi Akashi (3), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
Ramesh K. Akkina (85), Department of Microbiology and Immunology, School of
Medicine, University of California, Los Angeles, California 90024
Lisa M. Allison (209), Department of Medical Microbiology, London School of
Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom
Firelli V. Alonso-Caplen (179), Department of Microbiology, University of
Alabama in Birmingham, Birmingham, Alabama 35294
David D. Auperin (51), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
Thomas Bächi (247), Institute for Immunology and Virology, University of Zürich,
8028 Zürich, Switzerland
Sukla Basak (361), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
William J. Bean (315), Division of Virology and Molecular Biology, St. Jude
Children's Research Hospital, Memphis, Tennessee 38101
Serge Belloncik (3), Virology Research Centre, Institut Armand-Fr appier, Quebec
H7N 4Z3, Canada
David H. L. Bishop (3,51), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
'Present address: The Chemo-Sero-Therapeutic Research Institute, Kumamoto 860, Japan.
2Present address: Laboratories of Special Cancer Research, University of Alabama in Birmingham,
Birmingham, Alabama 35294.
XI
Xll CONTRIBUTORS
Timothy J. Bos (125), Department of Microbiology and Immunology, School of
Medicine, University of California, Los Angeles, California 90024
F. X. Bosch (273), Institut für Virologie, Justus-Liebig-Universität dessen,
D-6300 dessen, Federal Republic of Germany
G. W. Both (233), Division of Molecular Biology, CSIRO, North Ryde, New South
Wales, Australia
M. Bouloy (29), Unite de Virologie Moleculaire, Institut Pasteur, 75724 Paris
Cedex 15, France
Janet Braam (73), Molecular Biology and Virology Program, Graduate School of
Medical Sciences, Memorial Sloan-Kettering Cancer Center, New York, New
York 10021
George G. Brownlee (253), Sir William Dunn School of Pathology, University of
Oxford, Oxford 0X1 3RE, United Kingdom
D. J. Bücher (373), Department of Microbiology, Mount Sinai School of Medicine,
New York, New York 10029
Michael J. Buchmeier (193, 201, 209), Department of Immunology, Scripps Clinic
and Research Foundation, La Jolla, California 92037
Alicia J. Buckler-White (395), Laboratory of Infectious Diseases, National Institute
of Allergy and Infectious Diseases, National Institutes of Health, Bethesda,
Maryland 20205
Deborah A. Buonagurio (147), Mount Sinai School of Medicine of the City
University of New York, New York, New York 10029
A. S. Carver (355), Department of Biological Sciences, University of Warwick,
West Midlands CV4 7AL, United Kingdom
Andrew J. Caton (253), Sir William Dunn School of Pathology, University of
Oxford, Oxford 0X1 3RE, United Kingdom
Thomas M. Chambers (85), Department of Microbiology and Immunology, School
of Medicine, University of California, Los Angeles, California 90024
Robert M. Chanock (395), Laboratory of Infectious Diseases, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, Bethesda,
Maryland 20205
Purnell W. Choppin (131), The Rockefeller University, New York, New York 10021
W. Clark (45), MRC Virology Unit, Institute of Virology, Glasgow GH 5JR,
Scotland
J. C. S. Clegg (341), Public Health Laboratory Service, Centre for Applied
Microbiology and Research, Salisbury SR4 OJG, United Kingdom
Mary Lou Clements (395), Center for Vaccine Development, Department of
Medicine, University of Maryland School of Medicine, Baltimore, Maryland
21201
John P. M. Clerx3 (321), Institute for Medical Microbiology and Hygiene,
Technical University, 8000 Munich 40, Federal Republic of Germany
M. S. Collett (159), Molecular Genetics, Inc., Minnetonka, Minnesota 55343
3Present address: Department of Cellular and Developmental Biology, The University of Arizona,
Tucson, Arizona 85721.
CONTRIBUTORS Xlll
P. M. Colman (225), John Curtin School of Medical Research, Canberra City, ACT
2601, Australia, and CSIRO Division of Protein Chemistry, Melbourne,
Victoria 3052, Australia
Richard W. Compans (179, 361), Department of Microbiology, University of
Alabama in Birmingham, Birmingham, Alabama 35294
Nancy J. Cox (101, 253), Influenza Branch 7-106, Centers for Disease Control,
Atlanta, Georgia 30333
Janusz Dabrowski (289), Max-Planck-Institut für Medizinische Forschung,
Heidelberg, Federal Republic of Germany
Joel M. Dalrymple (21, 117, 159), U.S. Army Medical Research Institute of
Infectious Diseases, Fort Detrick, Frederick, Maryland 21701
Roelf Datema4 (187), Institut für Virologie, Justus-Liebig-Universität dessen,
D-6300 Giessen, Federal Republic of Germany
Alan R. Davis5 (125), Department of Microbiology and Immunology, School of
Medicine, University of California, Los Angeles, California 90024
Dan C. DeBorde (147, 379), School of Public Health, University of Michigan, Ann
Arbor, Michigan 48109
N. J. Dimmock (355), Department of Biological Sciences, University of Warwick,
West Midlands CV4 7AL, United Kingdom
Armen M. Donabedian (379), Department of Epidemiology, School of Public
Health, University of Michigan, Ann Arbor, Michigan 48109
R. R. Dourmashkin (373), Department of Microbiology, Mount Sinai School of
Medicine, New York, New York 10029
L. H. Elliott (201), Special Pathogens Branch, Division of Viral Disease, Centers
for Disease Control, Atlanta, Georgia 30333
Richard M. Elliott (13, 45, 349), MRC Virology Unit, Institute of Virology,
Glasgow Gil 5JR, Scotland
Yuki Eshita (3), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
John T. Finch (65), MRC Laboratory of Molecular Biology, Cambridge CB2 2PH,
United Kingdom
Frederick Fuller6 (3), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
S. Gerbaud (29), Unite de Virologie Moleculaire, Institut Pasteur, 75724 Paris,
Cedex 15, France
Walter Gerhard (233, 247), The Wistar Institute, Philadelphia, Pennsylvania 19104
Rudolf Geyer (289), Biochemisches Institut, Justus-Liebig-Universität dessen,
D-6300 dessen, Federal Republic of Germany
M. Girard (29), Unite de Virologie Moleculaire, Institut Pasteur, 75724 Paris
Cedex 15, France
4Present address: Department of Antiviral Chemotherapy, Astra Läkemedel AB, Södertälje, Sweden.
5Present address: Wyeth Laboratories, Radnor, Pennsylvania 19108.
6Present address: Department of Microbiology, Pathology, and Immunology, North Carolina State
University, Raleigh, North Carolina 27606.
XIV CONTRIBUTORS
J. P. Gonzalez7 (201), Office de la Recherche Scientifique et Technique Outre Mer,
Paris, France
J. A. Greenberg (373), Department of Microbiology, Mount Sinai School of
Medicine, New York, New York 10029
Anastasia Gregoriades8 (299), The Public Health Research Institute of the City of
New York, New York, New York 10016
Lynne F. Haber (239), Department of Biological Chemistry, School of Medicine,
University of California, Los Angeles, California 90024
Otto Haller9 (131), The Rockefeller University, New York, New York 10021
Joanna Hansen (139), Molecular Viral Biology Section, Laboratory of Infectious
Diseases, National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, Maryland 20205
Martinez J. Hewlett (17), Department of Cellular and Developmental Biology,
University of Arizona, Tucson, Arizona 85721
V. S. Hinshaw (267), Division of Virology and Molecular Biology, St. Jude
Children's Research Hospital, Memphis, Tennessee 38101
Robert S. Hodges (109), Department of Biochemistry and Medical Research
Council Group in Protein Structure and Function, University of Alberta,
Edmonton, Alberta T6G 2H7, Canada
Yasuhiro Hosaka (365), Department of Preventive Medicine, Research Institute for
Microbial Diseases, Osaka University, Osaka 565, Japan
Colin R. Howard (209), Department of Medical Microbiology, London School of
Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom
Takeshi Ihara (3), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
Lori D. Ishizawa (217), Department of Microbiology, California State University,
Long Beach, California 90840
Philip A. Jennings (65), Laboratory of Molecular Biology, Medical Research
Council Centre, Cambridge, United Kingdom
Guozhong Jing (109), Department of Medicine, University of Alberta, Edmonton,
Alberta T6G 2G3, Canada
Walter Keil (289), Institut für Virologie, Justus-Liebig-Universität dessen, D-6300
Giessen, Federal Republic of Germany
Alan P. Kendal (101, 253, 259), Influenza Branch 7-106, Centers for Disease
Control, Atlanta, Georgia 30303
E. D. Kilbourne (233), Department of Microbiology, Mount Sinai School of
Medicine, New York, New York 10029
M. P. Kiley (201), Special Pathogens Branch, Division of Viral Diseases, Centers
for Disease Control, Atlanta, Georgia 30333
7Present address: Special Pathogens Branch, Division of Viral Diseases, Centers for Disease Control,
Atlanta, Georgia 30333.
"Present address: New York College of Podiatric Medicine, New York, New York 10035.
9Present address: Institute for Immunology and Virology, University of Zürich, Zürich, Switzerland.
CONTRIBUTORS XV
Laura Kingsford (217), Department of Microbiology, California State University,
Long Beach, California 90840
Hans-Dieter Klenk (93, 289), Institut für Virologie, Justus-Liebig-Universität
dessen, D-6300 dessen, Federal Republic of Germany
Robert M. Krug (73), Molecular Biology and Virology Program, Memorial
Sloan-Kettering Cancer Center, New York, New York 10021
Mark Krystal (147), Mount Sinai School of Medicine of the City University of New
York, New York, New York 10029
Ching-Juh Lai (139, 167), Molecular Viral Biology Section, Laboratory of
Infectious Diseases, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland 20205
Robert A. Lamb10 (131), The Rockefeller University, New York, New York 10021
W. G. Laver (225), John Curtin School of Medical Research, Canberra City, ACT
2601, Australia
Ming-Fan Law (167), Laboratory of Pathology, National Cancer Institute,
Bethesda, Maryland 20205
Janice F. Lees (13, 45), MRC Virology Unit, Institute of Virology, Glasgow Gil
5JR, Scotland
Wai-Choi Leung (109), Department of Medicine, University of Alberta, Edmonton,
Alberta T6G 2G3, Canada
Hanna Lewicki (209), Department of Immunology, Scripps Clinic and Research
Foundation, La Jolla, California 92037
Bor-Chian Lin (167), Molecular Viral Biology Section, Laboratory of Infectious
Diseases, National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, Maryland 20205
G. Lloyd (341), Public Health Laboratory Service, Centre for Applied
Microbiology and Research, Salisbury SR4 OJG, United Kingdom
William T. London (395), National Institute of Neurological and Communicative
Disorders and Stroke, National Institutes of Health, Bethesda, Maryland
20205
H. F. Maassab (147, 379), School of Public Health, University of Michigan, Ann
Arbor, Michigan 48109
B. W. J. Mahy (173), Division of Virology, Laboratories Block, Addenbrooke s
Hospital, Cambridge CB2 2QQ, United Kingdom
Lewis Markoff (139), Molecular Viral Biology Section, Laboratory of Infectious
Diseases, National Institute of Allergy and Infectious Diseases, National
Institutes of Health, Bethesda, Maryland 20205
Yumiko Matsuoka (3, 179), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
'"Present address: Department of Biochemistry, Molecular, and Cell Biology, Northwestern Univer­
sity, Evanston, Illinois 60201.
XVI CONTRIBUTORS
John W. McCauley (281), Division of Virology, Department of Pathology,
University of Cambridge, Laboratories Block, Addenbrooke's Hospital,
Cambridge CB2 2QQ, United Kingdom
J. B. McCormick (201), Special Pathogens Branch, Division of Viral Diseases,
Centers for Disease Control, Atlanta, Georgia 30333
Jerry R. McGhee (307), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
Nancy L. McQueen (125), Department of Microbiology and immunology, School of
Medicine, University of California, Los Angeles, California 90024
Herbert Meier-Ewert (321), Institute for Medical Microbiology and Hygiene,
Technical University, 8000 Munich 40, Federal Republic of Germany
Suzanne M. Michalek (307), University of Alabama in Birmingham, Birmingham,
Alabama 35294
S. W. Mitchell (201), Special Pathogens Branch, Division of Viral Diseases,
Centers for Disease Control, Atlanta, Georgia 30333
Tsutomu Miyamoto (387), Department of Bacteriology, Nagasaki University
School of Medicine, Nagasaki 852, Japan
Kam Mong (109), Department of Medicine, University of Alberta, Edmonton,
Alberta T6G 2G3, Canada
Karin Müller (93), Institut für Virologie, Justus-Liebig-Universität dessen,
D-6300 dessen, Federal Republic of Germany
Brian R. Murphy (307, 395), Laboratory of Infectious Diseases, National Institute
of Allergy and Infectious Diseases, National Institutes of Health, Bethesda,
Maryland 20205
C. W. Naeve (267), Division of Virology and Molecular Biology, St. Jude
Children s Research Hospital, Memphis, Tennessee 38101
Susumu Nakada (147), Mount Sinai School of Medicine of the City University of
New York, New York, New York 10029
K. Nakajima (259), The Institute of Public Health, Tokyo 108, Japan
S. Nakajima (259), The Institute of Public Health, Tokyo 108, Japan
Debi P. Nayak (85, 125), Department of Microbiology and Immunology, School of
Medicine, University of California, Los Angeles, California 90024
Heiner Niemann (289), Institut für Virologie, Justus-Liebig-Universität dessen,
D-6300 dessen, Federal Republic of Germany
Michael B. A. Oldstone (59, 333, 361), Department of Immunology, Scripps Clinic
and Research Foundation, La Jolla, California 92037
Peter Palese (147), Mount Sinai School of Medicine, New York, New York 10029
N. Pardigon (29), Unite de Virologie Moleculaire, Institut Pasteur, 75724 Paris
Cedex 15, France
M. D. Parker (21, 159), Department of Viral Biology, Virology Division, U.S.
Army Medical Research Institute of Infectious Diseases, Fort Detrick,
Frederick, Maryland 21701
Asit K. Pattnaik (37), School of Science, Griffith University, Nathan, Queensland
4111, Australia
CONTRIBUTORS XV11
James C. Paulson (239), Department of Biological Chemistry, School of Medicine,
University of California, Los Angeles, California 90024
C. R. Penn (173), Division of Virology, Laboratories Block, Addenbrooke's
Hospital, Cambridge CB2 2QQ, United Kingdom
Susan M. Peters (379), Department of Epidemiology, School of Public Health,
University of Michigan, Ann Arbor, Michigan 48109
Craig R. Pringle11 (13, 45, 349), MRC Virology Unit, Institute of Virology,
Glasgow Gil 5JR, Scotland
Thomas J. Pritchett (239), Department of Biological Chemistry, School of
Medicine, University of California, Los Angeles, California 90024
A. F. Purchio (159), Molecular Genetics, Inc., Minnetonka, Minnesota 55343
Arlene Ramsingh12 (109), Department of Medicine, University of Alberta,
Edmonton, Alberta T6G 2G3, Canada
F. Lucy Raymond (253), Sir William Dunn School of Pathology, University of
Oxford, Oxford 0X1 3RE, United Kingdom
James S. Robertson13 (65), Division of Virology, University of Cambridge,
Addenbrooke s Hospital, Cambridge CB2 2QQ, United Kingdom
Gary N. Rogers (239), Department of Biological Chemistry, School of Medicine,
University of California, Los Angeles, California 90024
Victor Romanowski (51), Department of Microbiology, University of Alabama in
Birmingham, Birmingham, Alabama 35294
Pedro A. Romero (187), Institut für Virologie, Justus-Liebig-Universität dessen,
D-6300 dessen, Federal Republic of Germany
R. Rott (273), Institut für Virologie, Justus-Liebig-Universität dessen, D-6300
dessen, Federal Republic of Germany
Erling Rud (3), Virology Research Centre, Institut Armand-Frappier, Quebec H7N
4Z3, Canada
Aimo Salmi14 (333), Department of Immunology, Scripps Clinic and Research
Foundation, La Jolla, California 92037
Mark Salter (209), Department of Medical Microbiology, London School of
Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom
Connie S. Schmaljohn (117, 159), Department of Viral Biology, U.S. Army Medical
Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland
21701
Christoph Scholtissek (93), Institut für Virologie, Justus-Liebig-Universität
dessen, D-6300 dessen, Federal Republic of Germany
1 Present address: Department of Biological Sciences, University of Warwick, Coventry CV4 7AL,
United Kingdom.
,2Present address: Department of Human Genetics, Yale University School of Medicine, New Haven,
Connecticut 06510.
13Present address: National Institute for Biological Standards and Control, Hampstead, London,
United Kingdom.
14Present address: Department of Virology, University of Turko, Turko, Finland.